Patient info Open main menu

CALCICHEW® 500 mg CHEWABLE TABLETS – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: With or without prescription Details

Medicine strength:
500 mg
Contains active substance:
Similar medicines:

Patient leaflet - Calcichew 500 mg chewable tablets

1. WHAT CALCICHEW IS AND WHAT IT IS USED FOR

Calcichew is orange flavoured chewable tablets containing the active ingredient calcium. Calcium is found in the diet and is an important substance in bone formation.

Calcichew is used to treat and prevent calcium deficiency which may occur if your diet or lifestyle does not provide enough, or when body requirements are increased. This medicine may also be prescribed or recommended for certain bone conditions, for example osteoporosis, or during pregnancy. It may also be given to patients receiving kidney dialysis to remove the phosphate from the blood that cannot be removed by dialysis.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CALCICHEW

Do not take Calcichew if you:

  • are allergic (hypersensitive) to calcium or any of the other ingredients of this medicine (listed in section 6)
  • have a condition that causes excessive amounts of calcium in your blood or urine (hypercalcaemia or hypercalciuria)
  • have kidney stones.

Warnings and precautions

Talk to your doctor or pharmacist before taking Calcichew:

  • if you have osteoporosis (brittle bones) and are also unable to move around
  • if you are on long term treatment, especially if you are taking medicines for a heart disorder (cardiac glycosides), or diuretics (used in the treatment of high blood pressure or oedema)
  • if you have signs of impaired kidney function or a high tendency to kidney stone (calculus) formation
  • if you have cancer or any other conditions that may have affected your bones.

Your serum calcium or phosphate levels, or urinary calcium excretion must be monitored if you have any of the following conditions.

  • kidney problems
  • you are on long-term treatment with Calcichew
  • you are already taking additional doses of calcium

If you have increased calcium levels in the blood or develop signs of kidney problems, the dose of Calcichew should be reduced or the treatment discontinued.

Other medicines and Calcichew

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

In particular, the following medicines may interact with Calcichew:

  • thiazide diuretics (water tablets); your serum calcium levels should be monitored regularly.
  • cardiac glycosides (heart medicines); you should be monitored by electrocardiogram (ECG) and your serum calcium levels measured.
  • tetracycline antibiotics; these should be taken at least two hours before, or four to six hours afterwards. Calcium carbonate may interfere with the absorption of tetracycline preparations if taken at the same time.
  • levothyroxine (hormone used to treat thyroid deficiency); these should be taken at least four hours before, or after taking Calcichew.
  • Quinolone antibiotics (ciprofloxacin, lomefloxacin, norfloxacin, sparfloxacin); the effect of these medicines may be reduced if taken at the same time as calcium. Take quinolone antibiotics two hours before or six hours after taking Calcichew.
  • Bisphosphonates should be taken at least one hour before Calcichew.
  • Calcium salts may decrease the absorption of iron, zinc and strontium ranelate. Consequently iron, zinc or strontium ranelate preparations should be taken at least two hours before or after Calcichew.

If you are taking any of the above-mentioned medicines, your doctor will give you further instructions.

Taking Calcichew with food and drink

For treatment of calcium deficiency or use as an additional osteoporosis therapy, Calcichew can be taken with or without food and drink.

For use as a phosphate binder, Calcichew should be taken just before, during or just after each meal.

Pregnancy, breastfeeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Calcichew.

During pregnancy the daily intake should not exceed 2500 mg calcium (including food and supplementation). If you are pregnant, you may use Calcichew in case of a calcium deficiency.

Calcichew can be used during breastfeeding. Calcium passes into breast milk.

Driving and using machines

Calcichew has no known influence on the ability to drive or use machines.

Calcichew contains isomalt

Calcichew contains isomalt (E953): if you have been told by your doctor that you have an intolerance to some sugars, talk to your doctor before taking this medicine. May be harmful to teeth.

3. HOW TO TAKE CALCICHEW

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Dosage:

The recommended dose is:

For use as an additional osteoporosis therapy: One tablet 2 or 3 times a day.

For calcium deficiency: One tablet 2 or 3 times a day.

As a phosphate binder (for kidney failure patients on dialysis):

Your doctor will decide how many Calcichew you need. The label the pharmacist puts on your medicine will tell you exactly how many tablets to take.

Use in children

The recommended dose for children is one tablet 2 or 3 times a day.

The tablets can be chewed or sucked.

If you take more than you should

If you have taken more Calcichew than you should, talk to your doctor or pharmacist immediately.

If you accidentally take more Calcichew than you should, you may have an increase in your blood calcium levels. Symptoms of this are: excessive thirst, nausea, vomiting, constipation, abdominal pain, muscle weakness, tiredness, mental disturbances, lack of appetite, bone pain, having to pass more water than usual, kidney problems and, in severe cases, irregular heartbeat.

Very rarely in addition: irritability, continuing headache, lightheadedness, muscle spasms, twitches and tingling sensation.

If you forget to take Calcichew

Do not take a double dose to make up for a forgotten tablet.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking your medicine and see a doctor immediately if you experience any of the following side effects. These side effects may be a sign of milk-alkali syndrome (also called Burnett’s Syndrome) that is reported to occur very rarely (affects less than 1 in 10,000 people):

  • Frequent urge to urinate
  • Headache
  • Loss of appetite, nausea or vomiting
  • Unusual tiredness or weakness, along with elevated levels of calcium in the blood and kidney impairment.

Side effects may include:

Uncommon side effects (may affect up to 1 in 100 people):

  • excessive amounts of calcium in your blood (hypercalcaemia) or in your urine (hypercalcuria) may occur with large doses

Rare side effects (may affect up to 1 in 1,000 people):

  • nausea
  • diarrhoea
  • stomach ache
  • wind (flatulence)
  • constipation
  • heartburn (dyspepsia)

Very rare side effects (may affect less than 1 in 10,000 people):

  • rash
  • hives
  • itching

If you are taking Calcichew because you are having kidney dialysis, tell your doctor if you notice any white deposits on your skin.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. HOW TO STORE CALCICHEW

  • KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
  • Do not store Calcichew above 30°C. Store in the original container. Keep the container tightly closed to protect from moisture.
  • Do not use after the expiry date printed on the carton label or bottle.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
  • If the tablets become discoloured or show any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Calcichew contains

  • Each tablet contains 1250 mg of the active ingredient, calcium carbonate, equivalent to 500 mg of calcium.
  • The other ingredients are: xylitol (E967), povidone, isomalt (E953), mono- and di-fatty acid glycerides, magnesium stearate, orange flavour and sucralose (E955).

What Calcichew looks like and contents of the pack

Calcichew is round, white, uncoated convex and orange flavoured; they may have small specks.

Calcichew is available in white, plastic bottles of 60 and 90 tablets. Calcichew may also be marketed in boxes containing 2 bottles of 60 tablets in a single box.

Product Licence holder

Procured from within the EU and repackaged by the Product Licence holder: S&M Medical Ltd., Chemilines House, Alperton Lane, Wembley, HA0 1DX.

Manufacturer

This product is manufactured by-

  • TAKEDA AS, Drammensveien 852, NO-1383 Asker, Norway.
  • Takeda Pharma AS, 55B jaama Street, 63308 Polva, Estonia.
  • Tjoapack B.V., Columbusstraat, 4 , 7801 Emmen, The Netherlands.
  • Tjoapack Netherlands B.V., Nieuwe Donk 9, 4879 AC Etten-Leur, The Netherlands.

P PL: 19488/0678

Leaflet revision date: 29 August 2025

Blind or partially sighted? Is this leaflet hard to see or read? Call 02087997607 to obtain the leaflet in large print, tape, CD or Braille.

CALCICHEW® is a registered trade mark of Takeda AS, Norway.

Additional Information

Calcichew contains calcium designed to keep bones healthy. Calcium is an essential component of bones.

Requirements for calcium increase with age and, although many people obtain enough calcium from their diet, some people may require a supplement in order that their body has all the calcium it needs to maintain healthy bones.

People with diets and lifestyles that mean they will obtain less than the recommended intake of calcium are at risk of weakened bones. Prolonged lack of adequate calcium intake can lead to the development of osteoporosis, a condition where bones become weak to a level that minimal trauma (for example, a fall) can result in a fracture, most typically at the hip, spine or wrist.

Calcichew have been designed to give people, whose intake of calcium is low, a boost to the recommended amounts.

Maintaining healthy bones and helping to avoid osteoporosis is an important issue for many people. There are many ways that people can help themselves: regular exercise, a balanced diet with an adequate intake of calcium and, for some people, advice on how to prevent falls which may lead to fracture.

The National Osteoporosis Society (NOS) is a national charity dedicated to improving the diagnosis, prevention and treatment of osteoporosis. The NOS offers support to people with osteoporosis and raises awareness of the importance of healthy bones.

If you are concerned about osteoporosis, please contact the National Osteoporosis Society, Camerton, Bath BA2 0PJ. Tel: 01761 471 771, Fax: 01761 471 104 or email: info@nos.org.uk. *Registered Trademark

S0678 Leaflet Calcichew 500mg 20250829

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 19488/0678

Last revision stated in the text: 29 August 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Calcichew 500 mg chewable tablets

Prescription needed? Depends on the pack size: pharmacy medicine (P) – sold only in pharmacies, prescription-only medicine (POM)
Active substance Calcium carbonate
Strength 500 mg
Pharmaceutical form Chewable tablet
How is it taken Oral
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A12 Mineral supplements
      1. A12A Calcium supplements
        1. A12AA Calcium
          1. A12AA04 calcium carbonate
Marketing authorisation PLPI 19488/0678
Codes BNF 09050101

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.